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SHORT REPORT
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We aimed to validate a previously described six simple variable
(SSV) model that was developed from acute and sub-acute stroke
patients in our population that included hyper-acute stroke
patients. A Stroke Outcome Study enrolled patients from 2001 to
2002. Functional status was assessed at 6 months using the
modified Rankin Scale (mRS). SSV model performance was tested
in our cohort. 538 acute ischaemic (87%) and haemorrhagic
stroke patients were enrolled, 51% of whom presented to hospital
within 6 h of symptom recognition. At 6 months post-stroke, 42%
of patients had a good outcome (mRS (2). Stroke patients
presenting within 6 h of symptom recognition were significantly
older with higher stroke severity. In our Stroke Outcome Study
dataset, the SSV model had an area under the curve of 0.792 for
6 month outcomes and performed well for hyper-acute or post-
acute stroke, age , or >75 years, haemorrhagic or ischaemic
stroke, men or women, moderate and severe stroke, but poorly
for mild stroke. This study confirms the external validity of the SSV
model in our hospital stroke population. This model can therefore
be utilised for stratification in acute and hyper-acute stroke trials.
T
he six simple variable (SSV) model comprises easily
collected reliable variables: age, pre-stroke functional
status, living alone pre-stroke, being able to walk unaided,
lift both arms off the bed and have a normal verbal Glasgow
Coma Score. It predicts independent survival at 6 months
following stroke as well as more complex models, and has been
externally validated with area under the receiver operating
characteristic curve (AUC) of 0.84–0.88.1 2 It has been used to
adjust for case mix when comparing the quality of hospital
based stroke services3 and for stratification in randomised
trials.4 The SSV model was developed in patients presenting up
to 30 days post-stroke and has been validated in those
presenting within 2 days of stroke.1 It has not been previously
validated in hyper-acute stroke patients.
METHODS
We enrolled patients with stroke admitted consecutively
between 2001 and 2002 to the stroke service at the Halifax
Infirmary in the Stroke Outcomes Study. A neurologist
collected clinical variables, including a stroke severity score
(severity scored as mild (1–4), moderate (5–7) and severe (8–
10), depending on symptoms, signs and functional impair-
ment)4 and the six simple variables1 during the first assess-
ment. All patients had cranial CT or MRI performed acutely.
The main outcome measure was independent survival (mod-
ified Rankin score (mRS) (2) assessed at 6 months post-
stroke by telephone interview by a single assessor trained in
administering the mRS. At follow-up, patient information from
the discharge summary was available.
Data are presented as mean (SD) unless otherwise stated.
Comparisons between groups were made using x2 and Mann–
Whitney tests where appropriate, with significance at p,0.05.
SSV model prediction was calculated for each patient with a
stroke using the published coefficients.1 Model discrimination
was assessed using the AUC, computed by a non-parametric
method.5 An AUC of 1 implies perfect discrimination whereas an
AUC of 0.5 implies the model performs no better than chance. The
AUC for alive and independent at 6 months was determined
according to the following subgroups which we felt were
clinically important: age ,75 or >75 years old, the presence or
absence of intracerebral haemorrhage, stroke severity and time to
presentation (,6 h or >6 h). Calibration was assessed using
calibration curves (observed versus predicted probability of a
good outcome). To estimate the standard errors of AUCs and the
confidence intervals of the observed probability of good outcome,
bootstrapping was used by re-sampling 500 times. Mean AUC
values were compared using analyses of variance. All analyses
were conducted using SAS software, version 9.1 (SAS Institute
Inc., Cary, North Carolina, USA).
RESULTS
Of 598 patients admitted to the stroke service between 2001
and 2002, 38 refused consent, 13 had repeat admissions
(second admission excluded) and nine were lost to follow-up,
leaving a final study group of 538 patients (70 haemorrhagic
and 468 ischaemic strokes) (table 1). Forty-seven per cent of
patients were women. Compared with patients presenting>6 h
after stroke symptom recognition, hyper-acute patients (ie,
presenting ,6 h) were significantly older, with higher stroke
severity (table 1). At 6 months post-stroke, 42% had a good
outcome (mRS (2) and 24% were dead.
Testing the SSV model (variables listed in table 1) for a good
outcome at 6 months produced an AUC of 0.792 (SE 0.024)
with good calibration curves (available from authors). The SSV
model performed well for different subgroups: age , or >75
(AUC 0.800 (0.017) vs 0.846 (0.020); NS), haemorrhage versus
infarct (0.846 (0.038) vs 0.779 (0.031); p,0.05) and hyper-
acute versus post-acute (0.802 (0.031) vs 0.761 (0.034); NS). It
performed reasonably for moderate (0.675 (0.033)) and severe
stroke (0.782 (0.026); p,0.001 compared with moderate and
mild stroke) but no better than chance for mild stroke (0.457
(0.029)). Haemorrhagic stroke had a higher median stroke
severity compared with ischaemic stroke (8 vs 6; p = 0.0002).
DISCUSSION
We confirm that the SSV model for predicting independent
survival at 6 months has external validity in our stroke
population and we demonstrate for the first time that the
model performs well in a large population of hyper-acute stroke
patients, 11% of whom received thrombolysis. As shown
previously,1 the SSV model performed less well in minor stroke.
The reason for this needs further analysis, however, patients
initially seen with mild strokes at first assessment may develop
Abbreviations: AUC, area under the receiver operating characteristic
curve; mRS, modified Rankin score; SSV, six simple variable
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stroke progression or recurrence, or a new illness (such as a
myocardial infarction) which is not predicted by the SSV
model. Also, an outcome of mRS (2 may be a less
discriminating outcome in mild stroke as it was achieved in
84% of mild stroke patients. The model performs significantly
better for patients with higher stroke severity and for
haemorrhagic stroke, probably because the latter were more
severe than ischaemic strokes. The good model performance in
haemorrhagic stroke is important as the original study from
which the SSV model was developed may have underestimated
the proportion of patients with haemorrhagic stroke.1
The SSV model uses variables that can be easily collected
compared with some models that use scales that require
training (eg, the National Institutes of Health Stroke Scale).
This is noteworthy given that non-neurologists routinely assess
the majority of stroke patients in hospitals worldwide. It would
be of interest to directly compare SSV model performance with
models that use other stroke scales in validation cohorts.
Our population reflects inpatients from a tertiary stroke referral
centre and teaching hospital, and the SSV model would benefit
from further validation in less academic units. Our study benefits
from the low rate lost to follow-up and the high consent rate.
In conclusion, this study confirms the external validity of the
SSV model in hospitalised stroke patients, providing the first
evidence of validity in hyper-acute strokes. The SSV model can
therefore be utilised for stratification in acute stroke trials.
However, its use in clinical management (particularly in
selecting which patients are suitable for specific treatments—
eg, thrombolysis) cannot be recommended until it has been
evaluated in randomised controlled trials.
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Table 1 Patient characteristics and comparison of hyper-acute versus post-acute stroke
patients
Enrolled
patients
Hyper-acute
(,6 h)
Post-acute
(>6 h)
OR of a good
outcome
n 538 273 265
Stroke severity score* 6 (5–8) 7 (6–9) 6 (5–7) 0.49 (0.43–0.56)
Haemorrhagic stroke 70 (13%) 32 (12%) 38 (14%) 0.58 (0.26–1.00) 
Received tissue plasminogen activator 29 (5%) 29 (11%) 0 0.60 (0.23–1.40)
Six simple variables
(1) Age* 74 (61–80) 75 (65–81) 71 (59–79) 0.95 (0.91–0.98)
(2) Living alone pre-stroke 135 (25%) 64 (23%) 71 (27%) 1.1 (0.7–1.6)
(3) Independent pre-stroke 437 (81%) 214 (78%) 223 (84%) 53 (14–447)
(4) Verbal GCS = 5 347 (65%) 145 (53%) 202 (76%) 7.1 (4.5–11.5)
(5) Able to lift both arms off bed 353 (66%) 147 (54%) 206 (78%) 9.2 (5.6–15.5)
(6) Able to walk without assistance 150 (28%) 54 (20%) 96 (36%) 7.6 (4.8–12.1)
GCS, Glasgow Coma Score.
*Data are expressed as median (interquartile range) and odds ratios with 95% CI. Odds ratios for age and stroke severity
are per unit.
p,0.05, p,0.001.
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